CLINICAL_TRIALS
research
· 2022-11-07
Clinical Trial Update: Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women [Phase 2, Phase 3]
Summary
Phase 2/3 trial update evaluating immediate or deferred pre-exposure prophylaxis for HIV prevention in pregnant and lactating women.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of KwaZulu | Conditions: HIV-1-infection | Phase 2, Phase 3 | Status: COMPLETED